These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25082785)

  • 1. Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
    Pollyea DA; Gutman JA; Gore L; Smith CA; Jordan CT
    Haematologica; 2014 Aug; 99(8):1277-84. PubMed ID: 25082785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the acute myeloid leukemia stem cells.
    Krause A; Luciana M; Krause F; Rego EM
    Anticancer Agents Med Chem; 2010 Feb; 10(2):104-10. PubMed ID: 20184541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting mitochondrial respiration for the treatment of acute myeloid leukemia.
    Carter JL; Hege K; Kalpage HA; Edwards H; Hüttemann M; Taub JW; Ge Y
    Biochem Pharmacol; 2020 Dec; 182():114253. PubMed ID: 33011159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction in Acute Myeloid Leukemia - Implications for Novel Therapeutic Concepts.
    Konig H; Santos CD
    Curr Cancer Drug Targets; 2015; 15(9):803-21. PubMed ID: 26278711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery in acute myeloid leukemia.
    Kohlschütter J; Michelfelder S; Trepel M
    Expert Opin Drug Deliv; 2008 Jun; 5(6):653-63. PubMed ID: 18532921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting prostate cancer stem cells.
    Crea F; Mathews LA; Farrar WL; Hurt EM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1105-13. PubMed ID: 19925394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current clinical trials using new targeted therapies for myeloid leukemia and the research trends].
    Ishizawa J; Saya H
    Nihon Rinsho; 2009 Oct; 67(10):1932-7. PubMed ID: 19860193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the bone marrow microenvironment in acute leukemia.
    Karantanou C; Godavarthy PS; Krause DS
    Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for targeting malignant stem cells in leukemia.
    Guzman ML; Jordan CT
    Cancer Control; 2004; 11(2):97-104. PubMed ID: 15024346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche.
    Zong H; Sen S; Zhang G; Mu C; Albayati ZF; Gorenstein DG; Liu X; Ferrari M; Crooks PA; Roboz GJ; Shen H; Guzman ML
    Leukemia; 2016 Jul; 30(7):1582-6. PubMed ID: 26669973
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells.
    Zhang H; Luo J; Li Y; Henderson PT; Wang Y; Wachsmann-Hogiu S; Zhao W; Lam KS; Pan CX
    Nanomedicine; 2012 Oct; 8(7):1116-24. PubMed ID: 22197725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia stem cells: seek and destroy.
    Roboz GJ; Guzman M
    Expert Rev Hematol; 2009 Dec; 2(6):663-72. PubMed ID: 21082958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia.
    de Beauchamp L; Himonas E; Helgason GV
    Leukemia; 2022 Jan; 36(1):1-12. PubMed ID: 34561557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.
    Chomel JC; Turhan AG
    Oncotarget; 2011 Sep; 2(9):713-27. PubMed ID: 21946665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting leukemia stem cells.
    Mikkola HK; Radu CG; Witte ON
    Nat Biotechnol; 2010 Mar; 28(3):237-8. PubMed ID: 20212485
    [No Abstract]   [Full Text] [Related]  

  • 16. A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.
    Li Y; Chen K; Zhou Y; Xiao Y; Deng M; Jiang Z; Ye W; Wang X; Wei X; Li J; Liang J; Zheng Z; Yao Y; Wang W; Li P; Xu B
    Curr Cancer Drug Targets; 2015; 15(6):493-503. PubMed ID: 26282548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia.
    Brennan L; Narendran A
    Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the c-kit receptor in the treatment of acute myelogenous leukemia.
    Advani AS
    Curr Hematol Malig Rep; 2006 Jun; 1(2):101-7. PubMed ID: 20425339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of acute myeloid leukemia stem cells.
    Pollyea DA; Jordan CT
    Blood; 2017 Mar; 129(12):1627-1635. PubMed ID: 28159738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.
    Wouters R; Cucchi D; Kaspers GJ; Schuurhuis GJ; Cloos J
    Expert Rev Hematol; 2014 Dec; 7(6):791-805. PubMed ID: 25242511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.